Skip to content
Cell· Donghui Li, Alberto De Iaco, Kevin C. Ngan, Georgy Smyshlyaev, Ninad Kumbhojkar, Barrett E. Steinberg, Zohra Kalani, Lingbo Xia, Alexas Dolbee, Emily S. Kibbler, Miles C. Duncan, Ian Lin, Matthew S. Benczkowski, Lavanya Venkatesan, Andrea Calabria, Thomas A. Carter, Giulia I. Corsi, Trine A. Kristiansen, Gregory McAllister, Christopher Chase Bolt, Kimberly A. Harris, Jeffrey I. Boucher, Chunxi Zeng, Isha S. Dakhara, Xijia Wang, Shanmugapriya Sothiselvam, Ersin Akinci, Justin Strickland, Anubhuti Mathur, Christina Ferren, Jessica Desmond, Jason Rodriguez, James B. Rottman, Mohit Gupta, Lei Liu, Rahul Palchaudhuri, Z. Jane Wang, Robert J. Citorik, Jacob R. Rubens, Narahari S. Pujar, Michael C. Holmes, Cecilia Cotta-Ramusino·· 19 hours agoPickScore80

In vivo Gene Writing with engineered retrotransposons

In brief

Researchers computationally reconstructed, screened, and engineered non-LTR retrotransposons to obtain Gene Writers that achieve stable transgene integration in human cells via all-RNA delivery. After characterization and optimization, Gene Writers generated functional CAR-T cells in vivo in a humanized mouse model.

Why it matters

The workflow, from computational reconstruction and screening to in vivo CAR-T generation in humanized mice, offers a template for gene writing research.

Source: Cell

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org